Past Speakers

 

Mostafa Alabed, Health Economics Analyst, Evaluation and Impact Measurement Unit, Ministry Of Health - Kingdom Of Saudi Arabia

Mostafa Alabed | Health Economics Analyst, Evaluation and Impact Measurement Unit | Ministry Of Health - Kingdom Of Saudi Arabia » speaking at World EPA Congress

David Alderson, Director, Cogentia Healthcare Consulting

David Alderson | Director | Cogentia Healthcare Consulting » speaking at World EPA Congress

Ines Alves, President, ANDO Portugal

Ines Alves | President | ANDO Portugal » speaking at World EPA Congress

Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, Riziv-Inami

Francis Arickx | Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy | Riziv-Inami » speaking at World EPA Congress

Nadeem Ashraf, Head of CardioMetabolism for Medical Affairs, UK & Ireland, Boehringer Ingelheim

Nadeem Ashraf | Head of CardioMetabolism for Medical Affairs, UK & Ireland | Boehringer Ingelheim » speaking at World EPA Congress

Indranil Bagchi, Senior Vice President And Head Of Global Value And Access, Novartis

Indranil Bagchi | Senior Vice President And Head Of Global Value And Access | Novartis » speaking at World EPA Congress

Alex Bastian, Vice President, Value And Market Access, Galapagos NV

Alex Bastian | Vice President, Value And Market Access | Galapagos NV » speaking at World EPA Congress

Antje Behring, Head of Pharmaceuticals Department, G-BA

Antje Behring | Head of Pharmaceuticals Department | G-BA » speaking at World EPA Congress

Tomer Ben Zaken, Pricing And Alliance Manager, Takeda

Tomer Ben Zaken | Pricing And Alliance Manager | Takeda » speaking at World EPA Congress

Karsten Berndt, International HTA Lead, Myriad Genetics GmbH

Karsten Berndt | International HTA Lead | Myriad Genetics GmbH » speaking at World EPA Congress

Jennifer Cain Birkmose, Vice President, Global Head Of Patient Access And Community Engagement, Swedish Orphan Biovitrum

Jennifer Cain Birkmose | Vice President, Global Head Of Patient Access And Community Engagement | Swedish Orphan Biovitrum » speaking at World EPA Congress

Jesper Bjerggren, Senior Market Access Manager, Teva Denmark

Jesper Bjerggren | Senior Market Access Manager | Teva Denmark » speaking at World EPA Congress

Maria Alejandra Blanc, Director - Regulatory Affairs – Region South America, AbbVie

Maria Alejandra Blanc | Director - Regulatory Affairs – Region South America | AbbVie » speaking at World EPA Congress

Nadia Bodkin, Founder, Rare Advocacy Movement

Nadia Bodkin | Founder | Rare Advocacy Movement » speaking at World EPA Congress

Axel Boehnke, Director Market Access EU North, PTC Therapeutics

Axel Boehnke | Director Market Access EU North | PTC Therapeutics » speaking at World EPA Congress

Luc Boileau, Chairman And Chief Executive Officer, INESSS

Luc Boileau | Chairman And Chief Executive Officer | INESSS » speaking at World EPA Congress

Thomas Bols, Head of Government Affairs and Public Policy, EMEA & APAC, PTC Therapeutics

Thomas Bols | Head of Government Affairs and Public Policy, EMEA & APAC | PTC Therapeutics » speaking at World EPA Congress

Luciene Fontes Schluckebier Bonan, Innovation and HTA General Coordinator, Ministry of Health - Brazil

Luciene Fontes Schluckebier Bonan | Innovation and HTA General Coordinator | Ministry of Health - Brazil » speaking at World EPA Congress

Meindert Boysen, Deputy Chief Executive and Director of the Centre for Health Technology Evaluation, National Institute for Health and Care Excellence

Meindert Boysen | Deputy Chief Executive and Director of the Centre for Health Technology Evaluation | National Institute for Health and Care Excellence » speaking at World EPA Congress

Hassan Bruneo, Head of Market Access, Pricing & Policy CEMEA, Alnylam Switzerland Gmbh

Hassan Bruneo | Head of Market Access, Pricing & Policy CEMEA | Alnylam Switzerland Gmbh » speaking at World EPA Congress

Anna Bucsics, Project Advisor, Mechanism of Coordinated Access to orphan medicinal products (MoCA)

Anna Bucsics | Project Advisor | Mechanism of Coordinated Access to orphan medicinal products (MoCA) » speaking at World EPA Congress

Sandro Cesaro-Tadic, Head Strategic Product Pricing, Roche

Sandro Cesaro-Tadic | Head Strategic Product Pricing | Roche » speaking at World EPA Congress

Anjan Chatterjee, Senior Vice President - Global Head, Medical Affairs, Insmed Incorporated

Anjan Chatterjee | Senior Vice President - Global Head, Medical Affairs | Insmed Incorporated » speaking at World EPA Congress

Helene Chevrou-Severac, HEOR Director, Alexion

Helene Chevrou-Severac | HEOR Director | Alexion » speaking at World EPA Congress

Mouna Jameleddine Chtioui, Director of the Health Technology Assessment Department, INEAS - TUNISIA

Mouna Jameleddine Chtioui | Director of the Health Technology Assessment Department | INEAS - TUNISIA » speaking at World EPA Congress

Ali Ciger, Commercial Director, Pain, Pfizer

Ali Ciger | Commercial Director, Pain | Pfizer » speaking at World EPA Congress

Cliff Cox, Director, Evidencia

Cliff Cox | Director | Evidencia » speaking at World EPA Congress

Mike Crosher, Managing Director, Chugai Pharma UK

Mike Crosher | Managing Director | Chugai Pharma UK » speaking at World EPA Congress

Alan Crowther, General Manager, Global Pricing, Access and Digital Solutions, EVERSANA

Alan Crowther | General Manager, Global Pricing, Access and Digital Solutions | EVERSANA » speaking at World EPA Congress

Omar Dabbous, Vice President, Global Heor and Rwe, AveXis Inc

Omar Dabbous | Vice President, Global Heor and Rwe | AveXis Inc » speaking at World EPA Congress

Aletta de Beer, Product Owner Intensive Care, Pacmed

Aletta de Beer | Product Owner Intensive Care | Pacmed » speaking at World EPA Congress

Charles-Etienne de Cidrac, Director Of Health Insurance, AXA

Charles-Etienne de Cidrac | Director Of Health Insurance | AXA » speaking at World EPA Congress

Erwin De Cock, Executive Director, Real World and Late Phase, Syneos Health, Syneos Health

Erwin De Cock | Executive Director, Real World and Late Phase, Syneos Health | Syneos Health » speaking at World EPA Congress

Michele de Guise, Scientific Vice-President, INESSS

Michele de Guise | Scientific Vice-President | INESSS » speaking at World EPA Congress

Carla Deakin, Programme Director - Commercial And Managed Access, NICE

Carla Deakin | Programme Director - Commercial And Managed Access | NICE » speaking at World EPA Congress

Kate Dion, Value Communications Lead, 3D Communications

Kate Dion | Value Communications Lead | 3D Communications » speaking at World EPA Congress

Valentin Dodonov, Head of Market Access, BIOCAD

Valentin Dodonov | Head of Market Access | BIOCAD » speaking at World EPA Congress

Filippo Drago, Full Professor of Clinical Pharmacology, University of Catania

Filippo Drago | Full Professor of Clinical Pharmacology | University of Catania » speaking at World EPA Congress

Gilles Ducorroy, Head of RWE Services, Novartis

Gilles Ducorroy | Head of RWE Services | Novartis » speaking at World EPA Congress

Dominik Dziurda, Head Of Health Services Division, AOTMiT

Dominik Dziurda | Head Of Health Services Division | AOTMiT » speaking at World EPA Congress

Mercedes Echauri, Head of Pricing, Value and Access, Europe & Canada, Takeda

Mercedes Echauri | Head of Pricing, Value and Access, Europe & Canada | Takeda » speaking at World EPA Congress

Jaime Espin, Professor, Andalusian School Of Public Health

Jaime Espin | Professor | Andalusian School Of Public Health » speaking at World EPA Congress

Gina Ewy, Head Of Global Market Access, Hansa Biopharma

Gina Ewy | Head Of Global Market Access | Hansa Biopharma » speaking at World EPA Congress

Onno Faber, Co-Founder & CEO, Rarebase

Onno Faber | Co-Founder & CEO | Rarebase » speaking at World EPA Congress

Valerie Faillat, Head of Sanofi Espoir Foundation, sanofi

Valerie Faillat | Head of Sanofi Espoir Foundation | sanofi » speaking at World EPA Congress

Douglas Foerster, Former Head Market Access, Santhera Pharmaceuticals

Douglas Foerster | Former Head Market Access | Santhera Pharmaceuticals » speaking at World EPA Congress

Isabelle Ganache, Director of Bureau for Methodologies and Ethics, INESSS

Isabelle Ganache | Director of Bureau for Methodologies and Ethics | INESSS » speaking at World EPA Congress

Benjamin Gannon, Vice President International Access, Policy And Advocacy, Myriad genetics

Benjamin Gannon | Vice President International Access, Policy And Advocacy | Myriad genetics » speaking at World EPA Congress

Sandra Garitonandía, LS Industry Principal EMEA, Vistex

Sandra Garitonandía | LS Industry Principal EMEA | Vistex » speaking at World EPA Congress

Josie Godfrey, Director, JG Zebra Consulting

Josie Godfrey | Director | JG Zebra Consulting » speaking at World EPA Congress

Wim Goettsch, Special Hta-Advisor, Zorginstituut

Wim Goettsch | Special Hta-Advisor | Zorginstituut » speaking at World EPA Congress

Alfredo Gracia, Market Access Manager Spain, Baxter

Alfredo Gracia | Market Access Manager Spain | Baxter » speaking at World EPA Congress

Sylvie Greneche, Global Head of Market Access, General Medicines, Sanofi

Sylvie Greneche | Global Head of Market Access, General Medicines | Sanofi » speaking at World EPA Congress

Laura Guarga, Consultant of Pharmacoeconomic Department, CatSalut

Laura Guarga | Consultant of Pharmacoeconomic Department | CatSalut » speaking at World EPA Congress

Diego Guarin, Regional Market Access Lead , Latin America, Merck

Diego Guarin | Regional Market Access Lead , Latin America | Merck » speaking at World EPA Congress

Clare Hague, Therapy Area Market Access Lead, Hematology, Janssen Pharmaceutical

Clare Hague | Therapy Area Market Access Lead, Hematology | Janssen Pharmaceutical » speaking at World EPA Congress

Danielle Haller, Rare Disease Experience Expert, Rare Advocacy Movement

Danielle Haller | Rare Disease Experience Expert | Rare Advocacy Movement » speaking at World EPA Congress

Bernard Hamelin, Former Global Head Of Medical Evidence Generation, Sanofi

Bernard Hamelin | Former Global Head Of Medical Evidence Generation | Sanofi » speaking at World EPA Congress

Zahraa Hassan, Pharmacoeconomics Unit, Egyptian drug authority

Zahraa Hassan | Pharmacoeconomics Unit | Egyptian drug authority » speaking at World EPA Congress

Suzy Heafield, Head of Medicines Value, NHS England and Improvement

Suzy Heafield | Head of Medicines Value | NHS England and Improvement » speaking at World EPA Congress

Birgit Holz, Global Head of Contracting Innovation, Sanofi

Birgit Holz | Global Head of Contracting Innovation | Sanofi » speaking at World EPA Congress

Giorgio Iotti, Head Of Program Leadership And Control, Rare Disease Unit, Chiesi Farmaceutici SpA

Giorgio Iotti | Head Of Program Leadership And Control, Rare Disease Unit | Chiesi Farmaceutici SpA » speaking at World EPA Congress

Dawn Ireland, President, CDH International

Dawn Ireland | President | CDH International » speaking at World EPA Congress

Ulrike Jacobi, Head Of External Affairs And Market Access, Amgen

Ulrike Jacobi | Head Of External Affairs And Market Access | Amgen » speaking at World EPA Congress

Saira Jan, Vice-President & Chief Pharmacy Officer, Blue Cross Blue Shield of New Jersey

Saira Jan | Vice-President & Chief Pharmacy Officer | Blue Cross Blue Shield of New Jersey » speaking at World EPA Congress

Elizabeth Johnson, Director of Product Management, RxLightning Inc.

Elizabeth Johnson | Director of Product Management | RxLightning Inc. » speaking at World EPA Congress

Rosemary Jose, Senior Director, Strategic Market Access, Open Health

Rosemary Jose | Senior Director, Strategic Market Access | Open Health » speaking at World EPA Congress

Navin Joshi, Global Head of Pricing and Access Capabilities, GlaxoSmithKline

Navin Joshi | Global Head of Pricing and Access Capabilities | GlaxoSmithKline » speaking at World EPA Congress

Marcela Junqueira, Oncology Market Access Director - Latin America, Janssen Pharmaceutical

Marcela Junqueira | Oncology Market Access Director - Latin America | Janssen Pharmaceutical » speaking at World EPA Congress

Madhusudan Kabra, Director, Evidence Generation, Otsuka Pharmaceutical

Madhusudan Kabra | Director, Evidence Generation | Otsuka Pharmaceutical » speaking at World EPA Congress

Gomathi Kaliappan, Health Systems Strategy Leader - Global Access, Roche

Gomathi Kaliappan | Health Systems Strategy Leader - Global Access | Roche » speaking at World EPA Congress

Lisette Kaskens, Senior Global Market Access Manager, Advanced Accelerator Applications

Lisette Kaskens | Senior Global Market Access Manager | Advanced Accelerator Applications » speaking at World EPA Congress

Jolanda Koenders, Head Of Patient Value And Access, Takeda

Jolanda Koenders | Head Of Patient Value And Access | Takeda » speaking at World EPA Congress

Adam Kundzewicz, Global Head of Strategic Market Access Initiatives, Boehringer Ingelheim

Adam Kundzewicz | Global Head of Strategic Market Access Initiatives | Boehringer Ingelheim » speaking at World EPA Congress

Oliver Leatham, VP, Global Head of Commercial Strategy and EU Value & Access, Certara

Oliver Leatham | VP, Global Head of Commercial Strategy and EU Value & Access | Certara » speaking at World EPA Congress

Jost Leemhuis, Head Of Safety Science, Roche

Jost Leemhuis | Head Of Safety Science | Roche » speaking at World EPA Congress

Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer

Friedhelm Leverkus | Director Health Technology Assessment And Outcomes Research | Pfizer » speaking at World EPA Congress

Gavin Lewis, Vice President For Value, Access And Policy, Amgen

Gavin Lewis | Vice President For Value, Access And Policy | Amgen » speaking at World EPA Congress

Nanxin (Nick) Li, Senior Director and Head, Health Economics and Outcomes Research (HEOR), uniQure

Nanxin (Nick) Li | Senior Director and Head, Health Economics and Outcomes Research (HEOR) | uniQure » speaking at World EPA Congress

Edmund Lim, Executive Director, We CARE Journey

Edmund Lim | Executive Director | We CARE Journey » speaking at World EPA Congress

Catarina Lopes Pereira, Global Market Access Manager, Medac

Catarina Lopes Pereira | Global Market Access Manager | Medac » speaking at World EPA Congress

Chris Lundy, Community-based Experience Professional, Rare Advocacy Movement

Chris Lundy | Community-based Experience Professional | Rare Advocacy Movement » speaking at World EPA Congress

Elena Lungu, Manager Of Policy Development, Government of Canada

Elena Lungu | Manager Of Policy Development | Government of Canada » speaking at World EPA Congress

Richard Macaulay, Vice President, Global Pricing and Market Access, PRECISIONadvisors

Richard Macaulay | Vice President, Global Pricing and Market Access | PRECISIONadvisors » speaking at World EPA Congress

Alastair Macdonald, Senior Vice President Of Real World And Late Phase, Syneos Health

Alastair Macdonald | Senior Vice President Of Real World And Late Phase | Syneos Health » speaking at World EPA Congress

Mark Macgregor, Medical Director and Chair, New Drugs Committee, Scottish Medicines Consortium, Golden Jubilee National Hospital

Mark Macgregor | Medical Director and Chair, New Drugs Committee, Scottish Medicines Consortium | Golden Jubilee National Hospital » speaking at World EPA Congress

Andrea Mantovani, Former Market Access Executive, independent

Andrea Mantovani | Former Market Access Executive | independent » speaking at World EPA Congress

Marco Marchetti, Director Of The National Center For Health Technology Assessment, Istituto Superiore di Sanita

Marco Marchetti | Director Of The National Center For Health Technology Assessment | Istituto Superiore di Sanita » speaking at World EPA Congress

Caroline Mathie, Vice President, Rare Diseases, The Planning Shop International Ltd

Caroline Mathie | Vice President, Rare Diseases | The Planning Shop International Ltd » speaking at World EPA Congress

Dan McLean, Senior Manager, Pan-Canadian Pharmaceutical Alliance Office

Dan McLean | Senior Manager | Pan-Canadian Pharmaceutical Alliance Office » speaking at World EPA Congress

Christopher Missling, President, Anavex Life Sciences

Christopher Missling | President | Anavex Life Sciences » speaking at World EPA Congress

Erin Mistry, SVP, Head of Payer Strategy, Gov’t Affairs and Trade Relations, CorMedix Inc

Erin Mistry | SVP, Head of Payer Strategy, Gov’t Affairs and Trade Relations | CorMedix Inc » speaking at World EPA Congress

Vladimir Mladov, HTA Manager, BIOCAD

Vladimir Mladov | HTA Manager | BIOCAD » speaking at World EPA Congress

Paolo Morgese, EU Director Market Access & Member Relations, Alliance for Regenerative Medicine

Paolo Morgese | EU Director Market Access & Member Relations | Alliance for Regenerative Medicine » speaking at World EPA Congress

Thomas Mueller, Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology, Federal Ministry of Health Germany

Thomas Mueller | Head Of Directorate General 1 - Drugs, Medical Devices, Biotechnology | Federal Ministry of Health Germany » speaking at World EPA Congress

Michael Muller, Head Of Market Access, Western Europe, Sun Pharma

Michael Muller | Head Of Market Access, Western Europe | Sun Pharma » speaking at World EPA Congress

Diane Munch, Head of Global Pricing, Patient & Health Impact, Pfizer

Diane Munch | Head of Global Pricing, Patient & Health Impact | Pfizer » speaking at World EPA Congress

Nuriya Musina, Head Of Development, Federal State Budgetary Institution, The Center For Healthcare Quality Assessme, Ministry of Health Russian Federation

Nuriya Musina | Head Of Development, Federal State Budgetary Institution, The Center For Healthcare Quality Assessme | Ministry of Health Russian Federation » speaking at World EPA Congress

Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)

Alexander Natz | Secretary General | European Confederation of Pharmaceutical Entrepreneurs (Belgium) » speaking at World EPA Congress

Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical

Enkeleida Nikai | Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea) | Janssen Pharmaceutical » speaking at World EPA Congress

Mark Nuijten, Chief Executive Officer, A2M - Minerva

Mark Nuijten | Chief Executive Officer | A2M - Minerva » speaking at World EPA Congress

Pier Paolo Olimpieri, Data Analyst Coordinator, Monitoring Registries Office, AIFA

Pier Paolo Olimpieri | Data Analyst Coordinator, Monitoring Registries Office | AIFA » speaking at World EPA Congress

Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma

Melvin Olson | Global Head Rwd Strategy And Innovation | Novartis Pharma » speaking at World EPA Congress

Amer Omar, Head of Access & Reimbursement EMEA Neuroscience - Rare & Genetic Disease, Lupin

Amer Omar | Head of Access & Reimbursement EMEA Neuroscience - Rare & Genetic Disease | Lupin » speaking at World EPA Congress

Robert Orzechowski, Chief Operating Officer, Lancaster Cancer Centre

Robert Orzechowski | Chief Operating Officer | Lancaster Cancer Centre » speaking at World EPA Congress

Mario Ouwens, Group Director Medical & Payer Evidence Statistics, Astra Zeneca

Mario Ouwens | Group Director Medical & Payer Evidence Statistics | Astra Zeneca » speaking at World EPA Congress

Elena Panitti, Global Rwe Capability Building Lead, Novartis

Elena Panitti | Global Rwe Capability Building Lead | Novartis » speaking at World EPA Congress

Detlev Parow, Head Pharmaceutical Department, DAK-Gesundheit

Detlev Parow | Head Pharmaceutical Department | DAK-Gesundheit » speaking at World EPA Congress

Diogo Teixeira Pereira, Policy Analyst - Office for International Relations and Development, Infarmed

Diogo Teixeira Pereira | Policy Analyst - Office for International Relations and Development | Infarmed » speaking at World EPA Congress

Ed Pezalla, Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy, Aetna; a CVS Pharmacy Health Company

Ed Pezalla | Former Vice President, National Medical Director For Pharmaceutical Policy And Strategy | Aetna; a CVS Pharmacy Health Company » speaking at World EPA Congress

Andres Pichon Riviere, Executive Director And Director Of Health Technology Assessment And Economic Evaluations, I.E.C.S.

Andres Pichon Riviere | Executive Director And Director Of Health Technology Assessment And Economic Evaluations | I.E.C.S. » speaking at World EPA Congress

Lara Pippo, Head Of Market Access, CSL Behring

Lara Pippo | Head Of Market Access | CSL Behring » speaking at World EPA Congress

Ana Plata, Global Head of Pricing, UCB

Ana Plata | Global Head of Pricing | UCB » speaking at World EPA Congress

Adam Plich, Managing Director, Plich Advisory

Adam Plich | Managing Director | Plich Advisory » speaking at World EPA Congress

Mary Lynne Van Poelgeest-Pomfret, President, President of the World Federation for Incontinence and Pelvic Pain - WFIP

Mary Lynne Van Poelgeest-Pomfret | President | President of the World Federation for Incontinence and Pelvic Pain - WFIP » speaking at World EPA Congress

Angelina Irizari Policarpio, Head of HEOR and RWE Field Communications Team, Eisai

Angelina Irizari Policarpio | Head of HEOR and RWE Field Communications Team | Eisai » speaking at World EPA Congress

Nadia Quignot, Director, Decision Analytics & Real World Evidence, Certara

Nadia Quignot | Director, Decision Analytics & Real World Evidence | Certara » speaking at World EPA Congress

Marco Rauland, Vice President Global Market Access & Pricing Strategic Planning, Merck Group

Marco Rauland | Vice President Global Market Access & Pricing Strategic Planning | Merck Group » speaking at World EPA Congress

Laurene Redding, Head, Value, Access & Policy, BeiGene

Laurene Redding | Head, Value, Access & Policy | BeiGene » speaking at World EPA Congress

Vijay Reddy, Senior Director - Global Market Access Strategy - Biologics, Biocon Biologics

Vijay Reddy | Senior Director - Global Market Access Strategy - Biologics | Biocon Biologics » speaking at World EPA Congress

Isabell Remus, Head Biosimilars & Specialty Business, Europe, Sandoz

Isabell Remus | Head Biosimilars & Specialty Business, Europe | Sandoz » speaking at World EPA Congress

Andreia Ribeiro, Director, Lifescience Dynamics Ltd

Andreia Ribeiro | Director | Lifescience Dynamics Ltd » speaking at World EPA Congress

Trevor Richter, Director, Pharmaceutical Reviews, CADTH

Trevor Richter | Director, Pharmaceutical Reviews | CADTH » speaking at World EPA Congress

Kevin Rieger, Head Of Public And Governmental Affairs Dach, Ipsen Pharma Gmbh

Kevin Rieger | Head Of Public And Governmental Affairs Dach | Ipsen Pharma Gmbh » speaking at World EPA Congress

Shirin Rizzardo, Director of Specialty Medicines, Ministry of Health, British Columbia

Shirin Rizzardo | Director of Specialty Medicines | Ministry of Health, British Columbia » speaking at World EPA Congress

Kay-Diene Robinson, rare360 DEI Expert, Rare Advocacy Movement

Kay-Diene Robinson | rare360 DEI Expert | Rare Advocacy Movement » speaking at World EPA Congress

Juan Roman, Vice President, Global Market Access, HEOR and Pricing, Krystal Biotech

Juan Roman | Vice President, Global Market Access, HEOR and Pricing | Krystal Biotech » speaking at World EPA Congress

Igor Rudychev, Vice President, Enterprise Analytics, Horizon Therapeutics

Igor Rudychev | Vice President, Enterprise Analytics | Horizon Therapeutics » speaking at World EPA Congress

Asmaa Saad, Head of the Pharmacoeconomics unit, Egyptian drug authority

Asmaa Saad | Head of the Pharmacoeconomics unit | Egyptian drug authority » speaking at World EPA Congress

Ryan Saadi, CEO, Tevogen Bio

Ryan Saadi | CEO | Tevogen Bio » speaking at World EPA Congress

Marcelo Sal, Head of Market Access and Pricing, South Cone of South America, PTC Therapeutics

Marcelo Sal | Head of Market Access and Pricing, South Cone of South America | PTC Therapeutics » speaking at World EPA Congress

Gustavo Saraiva Dos Anjos, Global Market Access Director For Biologics, GlaxoSmithKline

Gustavo Saraiva Dos Anjos | Global Market Access Director For Biologics | GlaxoSmithKline » speaking at World EPA Congress

Marie Theres Schmidt, Director Market Access And Government Affairs, Edwards Lifesciences

Marie Theres Schmidt | Director Market Access And Government Affairs | Edwards Lifesciences » speaking at World EPA Congress

Gundula Schneidewind, Head Ethics And Compliance, Europe And Canada, Takeda

Gundula Schneidewind | Head Ethics And Compliance, Europe And Canada | Takeda » speaking at World EPA Congress

Michael Schroter, Partner, VIOPAS Partners

Michael Schroter | Partner | VIOPAS Partners » speaking at World EPA Congress

Martin Schuchardt, Global Market Access Lead, Almirall

Martin Schuchardt | Global Market Access Lead | Almirall » speaking at World EPA Congress

Ayman Semaan, Head of Market Access, Algorithm

Ayman Semaan | Head of Market Access | Algorithm » speaking at World EPA Congress

Maja Sercic, Policy & Science Manager, Medicines for Europe

Maja Sercic | Policy & Science Manager | Medicines for Europe » speaking at World EPA Congress

Alexis Serlin, Head, Asia Cluster, Novartis

Alexis Serlin | Head, Asia Cluster | Novartis » speaking at World EPA Congress

Jonas Sertorio, Innovation and HTA Consultant, Ministry of Health - Brazil

Jonas Sertorio | Innovation and HTA Consultant | Ministry of Health - Brazil » speaking at World EPA Congress

Rita Shorjian, Business Unit Director – Gulf Countries, Specialty, HCV & Oncology, AbbVie

Rita Shorjian | Business Unit Director – Gulf Countries, Specialty, HCV & Oncology | AbbVie » speaking at World EPA Congress

Heather Shorten, Executive Director, Pompe Alliance

Heather Shorten | Executive Director | Pompe Alliance » speaking at World EPA Congress

Matt Slabbert, Global Head, Value & Access Policy, Bayer Pharmaceuticals

Matt Slabbert | Global Head, Value & Access Policy | Bayer Pharmaceuticals » speaking at World EPA Congress

Valeriia Sokolova, Health Economics Manager, BIOCAD

Valeriia Sokolova | Health Economics Manager | BIOCAD » speaking at World EPA Congress

Daniel Sperber, Senior Economist, Pan-Canadian Pharmaceutical Alliance Office

Daniel Sperber | Senior Economist | Pan-Canadian Pharmaceutical Alliance Office » speaking at World EPA Congress

Deanna Steinle, Rare Disease Experience Expert, Rare Advocacy Movement

Deanna Steinle | Rare Disease Experience Expert | Rare Advocacy Movement » speaking at World EPA Congress

Giovanni Tafuri, Director, International Pricing & Reimbursement and Policy Strategy, Apellis Pharmaceuticals

Giovanni Tafuri | Director, International Pricing & Reimbursement and Policy Strategy | Apellis Pharmaceuticals » speaking at World EPA Congress

Bertrand Tardivel, General Manager, Frehel/ContrAST

Bertrand Tardivel | General Manager | Frehel/ContrAST » speaking at World EPA Congress

Samuel Taylor, Emerging Markets Strategic Pricing Lead, Pfizer

Samuel Taylor | Emerging Markets Strategic Pricing Lead | Pfizer » speaking at World EPA Congress

Chris Teale, Vice President Market Access, Ipsos MORI UK Ltd

Chris Teale | Vice President Market Access | Ipsos MORI UK Ltd » speaking at World EPA Congress

Daria Tolkacheva, Head of Health Economics, BIOCAD

Daria Tolkacheva | Head of Health Economics | BIOCAD » speaking at World EPA Congress

Amardeep Udeshi, Partner, EVERSANA

Amardeep Udeshi | Partner | EVERSANA » speaking at World EPA Congress

Sheela Upadhyaya, Accelerated Access Collaborative Relationship & Delivery Lead & HST Specialist, National Institute for Health and Care Excellence

Sheela Upadhyaya | Accelerated Access Collaborative Relationship & Delivery Lead & HST Specialist | National Institute for Health and Care Excellence » speaking at World EPA Congress

Inneke Van De Vijver, Strategic Advisor - Reimbursement Pharmaceuticals, R.I.Z.I.V. I.N.A.M.I. National Health Insurance Agency

Inneke Van De Vijver | Strategic Advisor - Reimbursement Pharmaceuticals | R.I.Z.I.V. I.N.A.M.I. National Health Insurance Agency » speaking at World EPA Congress

Erik Van Den Berg, Chief Executive Officer, A.M. Pharma

Erik Van Den Berg | Chief Executive Officer | A.M. Pharma » speaking at World EPA Congress

Bart Van Den Daele, External Affairs Director, Gilead Sciences

Bart Van Den Daele | External Affairs Director | Gilead Sciences » speaking at World EPA Congress

Goedele Van Haasteren, Hta Specialist, Swiss Federal Office of Public Health

Goedele Van Haasteren | Hta Specialist | Swiss Federal Office of Public Health » speaking at World EPA Congress

Kärt Veliste, Chief Specialist at Department of Medicines and Medical Devices, Haigekassa Estonia

Kärt Veliste | Chief Specialist at Department of Medicines and Medical Devices | Haigekassa Estonia » speaking at World EPA Congress

David Watson, Executive Director, Economic, Health and Commercial Policy, ABPI

David Watson | Executive Director, Economic, Health and Commercial Policy | ABPI » speaking at World EPA Congress

Anne Willemsen, Senior Project Manager, Joint Production Co-Lead Partner – Pharmaceuticals, Zorginstituut Nederland / EUnetHTA

Anne Willemsen | Senior Project Manager, Joint Production Co-Lead Partner – Pharmaceuticals | Zorginstituut Nederland / EUnetHTA » speaking at World EPA Congress

Lynn Wilson, Vice President, Myositis Support and Understanding

Lynn Wilson | Vice President | Myositis Support and Understanding » speaking at World EPA Congress

Natasa Zibelnik, Global Head Of Market Access, EUSA Pharma

Natasa Zibelnik | Global Head Of Market Access | EUSA Pharma » speaking at World EPA Congress

Peter Zimmermann, Sr. Director of Professional Services, Model N

Peter Zimmermann | Sr. Director of Professional Services | Model N » speaking at World EPA Congress

Fabrizio Zucca, Director Market Access Dach, Intercept Pharmaceuticals Inc

Fabrizio Zucca | Director Market Access Dach | Intercept Pharmaceuticals Inc » speaking at World EPA Congress

 

 

DOWNLOAD PROSPECTUS

Get Involved

 

To sponsor or exhibit:


Edmond Rama
+44 (0)207 092 1052

edmond.rama@terrapinn.com

To speak:


Chris Shanks
+44 (0)207 092 1151

chris.shanks@terrapinn.com